JIC
RMD icon

Johnson Investment Counsel’s ResMed RMD Stock Holding History

Johnson Investment Counsel’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$417K Buy
1,859
+51
+3% +$12.7K ﹤0.01% 632
2025
Q4 		$436K Sell
1,808
-57
-3% -$14.6K ﹤0.01% 580
2025
Q3 		$511K Buy
1,865
+200
+12% +$54.6K ﹤0.01% 567
2025
Q2 		$430K Buy
1,665
+45
+3% +$10.7K ﹤0.01% 583
2025
Q1 		$363K Hold
1,620
– – ﹤0.01% 598
2024
Q4 		$371K Buy
+1,620
New +$390K ﹤0.01% 594

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Johnson Investment Counsel's RMD Position: Q1 2026 in Review

Johnson Investment Counsel increased its ResMed (RMD) stake by 2.8% in Q1 2026, buying an estimated $12.7K and bringing the position to 1,859 shares worth $417K. The position accounts for ﹤0.01% of the portfolio, ranked #632.

Johnson Investment Counsel first reported a position in RMD in Q4 2024 and has held it in 6 quarters since. The position peaked at $511K in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Johnson Investment Counsel held 1,859 shares of ResMed worth $417K as of Q1 2026.
  • Johnson Investment Counsel bought 51 ResMed shares in Q1 2026, an estimated $12.7K.
  • ResMed made up ﹤0.01% of Johnson Investment Counsel's portfolio in Q1 2026, its #632 holding.
  • Johnson Investment Counsel first reported a position in ResMed in Q4 2024 and has held it in 6 quarters since.
  • Johnson Investment Counsel's ResMed position peaked at $511K in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Johnson Investment Counsel's 13F filing for Q1 2026, filed 4 May 2026.